# Zhongnuo Venture Capital

> Zhongnuo Venture Capital is a VC fund backing Medical, 3D Printing and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Mar 2022
- Lead investor: 0%
- Last updated: Aug 2026

Zhongnuo Venture Capital is an investment Firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| 3D Printing | 1 | 50% |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series D | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| TenNor Therapeutics | TenNor Therapeutics is a clinical stage, product development company with a sharp focus on unmet medical needs in the area of infectious diseases. The company possesses a dual-acting drug discovery platform with several innovative products in various stages of preclinical and clinical development. The company is developing new drugs for thetreatment of Helicobacter pylori infections, prosthetic joint infections, multidrug-resistant Gram-negative infections and some other common and serious infectious diseases. | $41.6M | Series D | Mar 30, 2022 |  |
| Medvance | Medvance is one of the pioneers in the development of 3D printed PEEK medical implants. Evonik has always been our trusted raw material partner. This investment will further promote The company's development has helped us bring innovative solutions to patients and doctors in China and then to the world." |  | Series A | Sep 06, 2019 |  |

2 of 2 investments shown.

## Co-investors
- Besin Capital — VC Fund, 1 deal together
- [Evonik Venture Capital](https://shizune.co/investors/profile/evonik-venture-capital-gmbh) — VC Fund, 1 deal together
- [Galaxy Capital](https://shizune.co/investors/profile/galaxy-capital) — VC Fund, 1 deal together
- [Guolian New Venture](https://shizune.co/investors/profile/guolian-new-venture) — VC Fund, 1 deal together
- [Oriza Holdings](https://shizune.co/investors/profile/oriza-holdings) — VC Fund, 1 deal together
- [Puhua Capital](https://shizune.co/investors/profile/puhua-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Zhongnuo Venture Capital invest in?

Zhongnuo Venture Capital invests primarily in Medical, 3D Printing and Health Care startups, most often at Series A and Series D stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Zhongnuo Venture Capital last invest?

The most recent investment recorded for Zhongnuo Venture Capital closed in Mar 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co